z-logo
open-access-imgOpen Access
Association of Rivaroxaban vs Apixaban With Major Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation
Author(s) -
Wayne A. Ray,
Cecilia P. Chung,
C. Michael Stein,
Walter Smalley,
Eli E. Zimmerman,
William D. Dupont,
Adriana M. Hung,
James R. Daugherty,
Alyson L. Dickson,
Katherine T. Murray
Publication year - 2021
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2021.21222
Subject(s) - medicine , rivaroxaban , apixaban , atrial fibrillation , hazard ratio , stroke (engine) , intracerebral hemorrhage , cardiology , cohort , retrospective cohort study , warfarin , confidence interval , subarachnoid hemorrhage , mechanical engineering , engineering

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom